Skip to main content

In the News


New DNA Sequencing Facility in China Is Based on Cornell Startup, Pacific Biosciences of California, Inc.ís SMRT Sequencing Platform

Pacific Biosciences announced that Suqian Lakeside Pangu Gene Company (SLPC) established a new 1,500 square meter genomics facility in Tianjin, China dedicated to using PacBio Single Molecule, Real Time (SMRT®) Sequencing as the major sequencing platform for its translational medicine research projects.

Cornell Startup, Pacific Biosciences of California, Inc., Releases New DNA Sequencing Chemistry

Pacific Biosciences, provider of the PacBio RS II DNA Sequencing System, announced the release of new chemistry and software designed to enhance read length and accuracy for the study of human and other complex genomes.

Cornellís Newest Apple Varieties, SnapDragon™ and RubyFrost®, Come to Market

Production of Cornell’s newest apple varieties is ramping up with SnapDragon coming to market in limited quantities this November and RubyFrost becoming available through several retailers in January 2015.

Cornell Startup, Hurel Corporation, and ACEA Biosciences Announce Joint Marketing of Integrated Product Kits

Hurel, a provider of in vitro liver models that bring improved translational utility to pre-clinical drug development, and ACEA Biosciences, provider of impedance-based, label-free, real-time cell analysis instrumentation, announced that they will begin to offer their respective technologies combined together in a single, integrated cell-based assay platform with a launch planned for the first quarter of 2015.

Cornell Startup, Agronomic Technology Corp., Receives Armory Square Venturesí First Investment

Armory Square Ventures, a new venture fund, has closed its first investment as part of a $2.2 million round of financing for Agronomic Technology Corp.

New Technology Platform From Cornell Startup, Lumidyne Technologies, LLC, May Help Prevent HIV Infection

Researchers at Weill Cornell Medical College have developed technologies that allow investigators to watch HIV proteins on the virus’ surface, which may contribute to how it infects human immune cells.

Human Longevity, Inc. Is Now Using Cornell Startup, Pacific Biosciences of California, Inc.ís SMRT Technology

Human Longevity, Inc. has added Pacific Bioscience’s Single Molecule, Real-Time (SMRT®) Sequencing technology to their repertoire of DNA sequencing technologies to compile a comprehensive human genotype, microbiome, and phenotype database.

NIAGENô from Cornell licensee, ChromaDex Corp, Is the Featured Ingredient in a New Anti-Aging Supplement from Life Extension

Life Extension announced the launch of NAD+ Cell Regenerator™, a nutritional supplement that boosts vitality and supports healthy aging, featuring the ingredient NIAGEN™ from ChromaDex, a natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries. NIAGEN™ is the commercially available brand of Nicotinamide Riboside (NR), developed at Cornell.


Meet Aromella, the Newest Finger Lakes Wine Made from Cornell Grapes

Aromella is a limited release varietal white wine that is semi-dry white and marked by peach and tropical fruit aromas, similar to the trendy Italian wine, Moscato.

Johnston Associates Invests in Cornell Startup, Hurel Corporation, in Series A-3 Preferred Stock Financing

Hurel, provider of in vitro liver models and microfluidic assay platforms that improve the predictive reliability of pre-clinical drug development, announced that Johnston Assoicates, Inc. has become a participating investor in the company’s Series A-3 Preferred Stock financing.

Cornell Startup, Pacific Biosciences of California, Inc., Announces Use of SMRT Sequencing for de Novo Asian Reference Genomes

Pacific Biosciences, provider of the PacBio RS II DNA Sequencing System, announced that Macrogen, providers of genome sequencing services, has selected the PacBio Single Molecule, Real-Time (SMRT) Sequencing platform to create high-quality de novo human genome references for the Asian population. The current human genome reference was predominantly derived from a Caucasian individual and its utility is limited for researchers investigating certain diseases that differ genetically between ethnicities.

Cornell Scientists Engineer Plants for More Efficient Photosynthesis

A genetically engineered tobacco plant, developed with two genes from blue-green algae, holds promise for improving yields of many food crops.

Quantose™ Prediabetes Tests from Cornell Startup, Metabolon, Inc., Now Available in Europe

Metabolon, a life sciences company focused on the study of small molecules and an integral technology for understanding the function of biological systems, has partnered with Metdia Biotech, S.L. to commercialize its Quantose IR™ and Quantose IGT™ prediabetes tests in Spain, Portugal, France, Italy, the United Kingdom, Germany, Switzerland, Sweden, Norway, Denmark, Finland, the Netherlands, Belgium, and Austria.

SMRT Sequencing from Cornell Startup, Pacific Biosciences of California, Inc., Effectively Tracks Infectious Disease Pathogens

Pacific Biosciences, creators of the PacBio RS II DNA Sequencing System, announced the publication of several papers highlighting the advantages of Single Molecule, Real-Time (SMRT) Sequencing over short-read sequencing technologies for infectious disease applications.

Cornell Startup, BinOptics Corporation, Unveils New Lasers for Data Center Applications

BinOptics, developers of semiconductor lasers for the Telecom and Datacom industries, announced the availability of 25G lasers at four wavelengths, allowing 100G solutions for Data Centers that will provide an increase in data transfer with lower power consumption per bit of transferred data.

For archived news items, click here.